Krystal Biotech buy Jefferies Financial Group Inc.
Start price
05.03.25
/
50%
€166.55
Target price
05.03.26
€228.54
Performance (%)
39.96%
Price
27.02.26
€233.10
This prediction will end soon
Summary
This prediction is currently active. With a performance of 39.96% the BUY prediction by Jefferies_Financial_ is a big success. This prediction currently runs until 05.03.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 4.905% | 4.905% |
| iShares Core DAX® | -0,38 % | 1,09 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % |
| iShares S&P 500 | -0,71 % | 0,44 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $245.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat